Lupus & antiphospholipid syndrome

Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus

Rheumatology (Oxford)Published Genome-wide association study

Authors' conclusion

We identified a genome-wide significant locus intronic to AGAP1 for SLE disease activity burden as measured by AMSG.

Study context

Population
Adults with systemic lupus erytematosus (SLE) (ACR and/or SLICC criteria) from a tertiary care lupus clinic, genotyped, with ≥3 SLEDAI-2K measures88% female
Participants
538 adults
Outcome
Genetic risk loci for disease activity burden over time: adjusted mean SLEDAI-2K and GC (AMSG) score (genome-wide significance P < 5 × 10-8)
Methodological detailsmeta-analysis of array-stratified genome-wide association study (GWAS), adjusted for sex and five PCs, single tertiary care lupus clinic, colocalization analyses with eQTL, Median age at diagnosis 30.7 years (IQR 23.3, 41.7); mean follow-up 4.5 years (SD 0.95); 75% first clinic visit within 1 year of diagnosis
  • Meta-analysis of array-stratified GWAS
  • Adjusted for sex and five PCs
  • Single tertiary care lupus clinic
  • Colocalization analyses with eQTL
  • Median age at diagnosis 30.7 years (IQR 23.3, 41.7); mean follow-up 4.5 years (SD 0.95); 75% first clinic visit within 1 year of diagnosis

Pooled result

As reported in the abstract

Genome-wide significant SNP for AMSG: rs4561613, chromosome 2, intronic to AGAP1
Beta
0.34
SE
0.06
P
P = 4.16 × 10-9

Further pooled results

Median AMSG (adjusted mean SLEDAI-2K and GC score) in the cohort

Median AMSG 5.5 (Q25, Q75 = 3.2, 8.8)

Interferon gene scores and AMSG

Interferon gene scores significantly associated with AMSG (Beta = 0.02, SE = 8.70 × 10-3, P = 0.006)
  • Subset of patients

Colocalization with eQTL for top single nucleotide polymorphism (SNP)

No significant difference in gene expression for the top SNP

Original publication

Identified genetic locus for longitudinal disease activity in adults with systemic lupus erythematosus. Rheumatology (Oxford). Published 25 February 2025. doi:10.1093/rheumatology/keaf093

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.